Analytical Data
-
基因名
REG1A
- Application
-
别名
Lithostathine-1-alpha; ICRF; PSPS; PSPS1; REG
-
种属
Cynomolgus
-
表达系统
HEK293
-
标签
C-hFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
G8F4F8
-
表达区间
Q23-N166
-
蛋白长度
Full Length of Mature Protein
-
分子量
44 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
REG1A, also known as Regenerating Islet-Derived Protein 1 Alpha, is a member of the Reg family of proteins that play crucial roles in cellular growth, regeneration, and inflammation. Initially identified for its involvement in pancreatic islet regeneration, REG1A has garnered attention due to its potential implications in various pathological conditions, including diabetes, cancer, and inflammatory diseases. Elevated levels of REG1A are often observed in cancerous tissues, suggesting a role in tumor progression and metastasis. Research has indicated that REG1A may influence cellular processes such as apoptosis, cell proliferation, and immune responses, making it a focal point for exploring novel therapeutic strategies. Furthermore, its expression is closely linked to certain inflammatory conditions, raising interest in targeting REG1A for treating disorders characterized by excessive inflammation. Understanding the molecular mechanisms regulating REG1A expression and function can provide insights into its potential as a biomarker for disease prognosis and a target for drug development. Overall, REG1A stands at the intersection of regenerative medicine and oncology, highlighting its relevance in current biomedical research.
